All Stories

  1. Hospital admissions for HIV-infected prisoners in Italy

    Article • International Journal of Prisoner Health, June 2017, Emerald

    Dr Emanuele Pontali

  2. WHO strategies for the programmatic management of drug-resistant tuberculosis

    Article • Expert Review of Respiratory Medicine, June 2016, Taylor & Francis

    Dr Emanuele Pontali

  3. Unusual Presentation of Human Immunodeficiency Virus-Related Kaposi's Sarcoma

    Article • AIDS Research and Human Retroviruses, June 2016, Mary Ann Liebert Inc

    Dr Emanuele Pontali

  4. HCV and HBV co-infection in HIV+ prisoners

    Article • International Journal of Prisoner Health, June 2016, Emerald

    Dr Emanuele Pontali

  5. Advancing global programmatic management of latent tuberculosis infection for at risk populations

    Article • European Respiratory Journal, April 2016, European Respiratory Society (ERS)

    Dr Emanuele Pontali, H G

  6. Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence

    Article • European Respiratory Journal, January 2016, European Respiratory Society (ERS)

    Dr Emanuele Pontali

  7. Monitoring predictors of mortality: A necessary action to reach TB elimination

    Article • Revista Portuguesa de Pneumologia (English Edition), November 2015, Elsevier

    Dr Emanuele Pontali

  8. Management of drug resistantTB in patients with HIV co-infection

    Article • Expert Opinion on Pharmacotherapy, October 2015, Informa Healthcare

    Dr Emanuele Pontali

  9. New anti-tuberculosis drugs and regimens: 2015 update

    Article • ERJ Open Research, May 2015, European Respiratory Society (ERS)

    Dr Emanuele Pontali

  10. Multidrug-Resistant Tuberculosis in Europe, 2010–2011

    Article • Emerging Infectious Diseases, March 2015, Centers for Disease Control and Prevention (CDC)

    Dr Valeriu Crudu, Dr Valeriu Crudu, Dr Simon Tiberi, Dr Emanuele Pontali, Dr Frank van Leth

  11. Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis

    Article • Expert Review of Anti-infective Therapy, February 2015, Taylor & Francis

    Dr Emanuele Pontali

  12. Effect of Aging, Glucose Level, and HIV Viral Load on Response to Treatment with Pegylated Interferon Plus Ribavirin in HIV/HCV Co-Infected Women

    Article • Journal of Women s Health, February 2015, Mary Ann Liebert Inc

    Dr Emanuele Pontali

  13. Specific Issues in the Management of Hepatocellular Carcinoma in Hepatitis B Virus/Hepatitis C Virus-Human Immunodeficiency Virus Co-infected Patients

    Article • International STD Research & Reviews, January 2015, Sciencedomain International

    Dr Emanuele Pontali

  14. Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios

    Article • European Respiratory Journal, December 2014, European Respiratory Society (ERS)

    Dr Emanuele Pontali

  15. Unusual Presentation of Visceral Leishmaniasis in an HIV-Infected Patient

    Article • AIDS Research and Human Retroviruses, September 2014, Mary Ann Liebert Inc

    Dr Emanuele Pontali

  16. A new paradigm for multidrug-resistant tuberculosis?

    Article • The International Journal of Tuberculosis and Lung Disease, August 2014, International Union Against Tuberculosis and Lung Disease

    Dr Emanuele Pontali

  17. OPERA: use of pegylated interferon plus ribavirin for treating hepatitis C/HIV co-infection in interferon-naive patients

    Article • Antiviral Therapy, January 2014, International Medical Press

    Dr Emanuele Pontali

  18. Cytopenias during treatment of HIV–HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study

    Article • Antiviral Therapy, January 2014, International Medical Press

    Dr Emanuele Pontali

  19. An unexpected Streptococcus pneumoniae strain

    Article • Journal of Chemotherapy, December 2013, Taylor & Francis

    Dr Giovanni Cenderello, Dr Emanuele Pontali

  20. Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation

    Article • Proceedings of the National Academy of Sciences, July 2013, Proceedings of the National Academy of Sciences

    Dr Emanuele Pontali

  21. Drug-resistant tuberculosis

    Article • Current Opinion in Pulmonary Medicine, May 2013, Wolters Kluwer Health

    Dr Emanuele Pontali

  22. F-02 Incidence and consequences of thrombocytopenia in 1523 HIV/HCV coinfected patients treated with PEGylated interferon and ribavirin

    Article • Digestive and Liver Disease, February 2013, Elsevier

    Dr Emanuele Pontali

  23. F-04 Incidence, predictors and management strategies of anemia in HIV/HCV coinfected patients treated with PEGylated interferon and ribavirin

    Article • Digestive and Liver Disease, February 2013, Elsevier

    Dr Emanuele Pontali

  24. OC-34 OPERA: the use of Pegylated interferon and ribavirin for the treatment of HCV/HIV coinfection in interferon-naïve patients in Italy

    Article • Digestive and Liver Disease, February 2013, Elsevier

    Dr Emanuele Pontali

  25. TB in migrants

    Article • December 2012, European Respiratory Society (ERS)

    Dr Emanuele Pontali

  26. Safety and efficacy of a raltegravir-based dual antiretroviral therapy in clinical practice

    Article • Journal of the International AIDS Society, November 2012, Wiley

    Dr Emanuele Pontali

  27. Could anti-HCV treatment prevent recurrence of hepatocellular carcinoma in HIV-infected patients? Two case reports

    Article • Infection, October 2012, Springer Science + Business Media

    Dr Emanuele Pontali

  28. Rediscovering high technology from the past: thoracic surgery is back on track for multidrug-resistant tuberculosis

    Article • Expert Review of Anti-infective Therapy, October 2012, Taylor & Francis

    Dr Emanuele Pontali

  29. Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India

    Article • PLoS ONE, December 2011, PLOS

    Dr Emanuele Pontali

  30. Tuberculosis and HIV co-infection: do we have a surveillance system in Europe?

    Article • European Respiratory Journal, November 2011, European Respiratory Society (ERS)

    Dr Emanuele Pontali

  31. Management of MDR-TB household contacts: how difficult is it to climb the mountain? [Editorial]

    Article • The International Journal of Tuberculosis and Lung Disease, September 2011, International Union Against Tuberculosis and Lung Disease

    Dr Emanuele Pontali

  32. Dedication to Dr. Raffaella Rosso (Late)

    Article • Current Pediatric Reviews, August 2011, Bentham Science Publishers

    Dr Emanuele Pontali

  33. Editorial [Hot Topic: The Evolving Challenges in Pediatric HIV Management (Guest Editors: Emanuele Pontali and Raffaella Rosso)]

    Article • Current Pediatric Reviews, August 2011, Bentham Science Publishers

    Dr Emanuele Pontali

  34. Improving Adherence to Combination Antiretroviral Therapy in Children with HIV Infection: Challenges and Possibilities

    Article • Current Pediatric Reviews, August 2011, Bentham Science Publishers

    Dr Emanuele Pontali

  35. Dedication to Dr. Raffaella Rosso (Late)

    Article • Current Pediatric Reviews, August 2011, Bentham Science Publishers

    Dr Emanuele Pontali

  36. High prevalence of vitamin D deficiency in HIV-infected patients: A case–control study

    Article • Bone, May 2011, Elsevier

    Dr Emanuele Pontali

  37. Guillain-Barré Syndrome with Fatal Outcome during HIV-1-Seroconversion: A Case Report

    Article • Case Reports in Infectious Diseases, January 2011, Hindawi Publishing Corporation

    Dr Emanuele Pontali

  38. Tick‐Borne Encephalitis (TBE) During a “Grand‐Tour” of Europe Clinically Manifesting in a TBE‐Free Region

    Article • Journal of Travel Medicine, March 2010, Oxford University Press (OUP)

    Dr Emanuele Pontali

  39. Erysipelothrix rhusiopathiae intra-abdominal abscess

    Article • International Journal of Infectious Diseases, January 2010, Elsevier

    Dr Emanuele Pontali

  40. Relevance of CD38 Expression on CD8 T Cells to Evaluate Antiretroviral Therapy Response in HIV-1-infected Youths

    Article • Scandinavian Journal of Immunology, January 2010, Wiley

    Dr Emanuele Pontali

  41. HIV-1 diversity among inmates of Italian prisons

    Article • Journal of Medical Virology, October 2008, Wiley

    Dr Emanuele Pontali

  42. Unexpected High Rate of Wild-Type HIV-1 Genotype Among Inmates Failing Antiretroviral Therapy

    Article • HIV Clinical Trials, October 2008, Taylor & Francis

    Dr Emanuele Pontali

  43. Imported Typhoid Fever With Hepatitis From Bangladesh: A Case of Delayed Response to Ceftriaxone?

    Article • Journal of Travel Medicine, September 2008, Oxford University Press (OUP)

    Dr Emanuele Pontali

  44. Prevalence of Hepatitis B virus and/or Hepatitis C virus co‐infections in prisoners infected with the Human Immunodeficiency Virus

    Article • International Journal of Prisoner Health, February 2008, Emerald

    Dr Emanuele Pontali

  45. Interactions of Antiretroviral Drugs with Anti-Infectives and Other Antiretrovirals

    Article • Chemotherapy, December 2006, Karger Publishers

    Dr Emanuele Pontali

  46. Antiretroviral Treatment in Correctional Facilities

    Article • HIV Clinical Trials, February 2005, Taylor & Francis

    Dr Emanuele Pontali

  47. Facilitating Adherence to Highly Active Antiretroviral Therapy in Children with HIV Infection

    Article • Pediatric Drugs, January 2005, Springer Science + Business Media

    Dr Emanuele Pontali

  48. Antiretroviral Treatment in Resource-limited Settings

    Article • Journal of Health Management, October 2003, SAGE Publications

    Dr Emanuele Pontali

  49. Pharmacokinetics and Pharmacodynamics of Nelfinavir Administered Twice or Thrice Daily to Human Immunodeficiency Virus Type 1-Infected Children

    Article • Clinical Infectious Diseases, June 2003, Oxford University Press (OUP)

    Dr Emanuele Pontali

  50. The relationship between ritonavir plasma trough concentration and virological and immunological response in HIV-infected children

    Article • HIV Medicine, April 2002, Wiley

    Dr Emanuele Pontali

  51. Preservation of clonal heterogeneity of the Pneumocystis carinii -specific CD4 T cell repertoire in HIV infected, asymptomatic individuals

    Article • Clinical & Experimental Immunology, April 2002, Wiley

    Dr Emanuele Pontali, Roberto Accolla

  52. Adherence to Combination Antiretroviral Treatment in Children

    Article • HIV Clinical Trials, December 2001, Taylor & Francis

    Dr Emanuele Pontali

  53. Analysis of the antigen specific T cell repertoires in HIV infection

    Article • Immunology Letters, November 2001, Elsevier

    Professor Arianna Loregian, Dr Emanuele Pontali, Roberto Accolla

  54. Active Hepatitis G Virus Infection in Perinatally HIV-Infected Children

    Article • HIV Clinical Trials, August 2001, Taylor & Francis

    Dr Emanuele Pontali

  55. Does HGV–HIV co-infection exist?

    Article • International Journal of Antimicrobial Agents, November 2000, Elsevier

    Dr Emanuele Pontali

  56. Compliance to combination antiretroviral therapy in HIV-1 infected children

    Article • International Journal of Antimicrobial Agents, November 2000, Elsevier

    Dr Emanuele Pontali

  57. Nutritional status changes in HIV-infected children receiving combined antiretroviral therapy including protease inhibitors

    Article • International Journal of Antimicrobial Agents, November 2000, Elsevier

    Dr Emanuele Pontali

  58. Possible Malignant Transformation of Benign Lymphoepithelial Parotid Lesions in Human Immunodeficiency Virus-Infected Patients: Report of Three Cases

    Article • Clinical Infectious Diseases, June 2000, Oxford University Press (OUP)

    Dr Emanuele Pontali

  59. Fluoroquinolones in the Treatment of Atypical Mycobacterial Infections in AIDS

    Article • Drugs, January 1999, Springer Science + Business Media

    Dr Emanuele Pontali